About OtoNexus
OtoNexus is a company based in Seattle (United States) founded in 2010 by Mark Moehring and Caitlin Cameron.. OtoNexus has raised $34.79 million across 13 funding rounds from investors including Children's Hospital of Philadelphia, HHS and Mindshift Capital. OtoNexus offers products and services including Ultrasound Otoscope. OtoNexus operates in a competitive market with competitors including 3Shape, CellScope, TympaHealth, Lantos and 3NT Medical, among others.
- Headquarter Seattle, United States
- Founders Mark Moehring, Caitlin Cameron
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Otonexus Medical Technologies Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$34.79 M (USD)
in 13 rounds
-
Latest Funding Round
$12.9 M (USD), Series C
Oct 20, 2022
-
Investors
Children's Hospital of Philadelphia
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OtoNexus
OtoNexus offers a comprehensive portfolio of products and services, including Ultrasound Otoscope. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects bacterial middle ear infections quickly and accurately.
Unlock access to complete
Funding Insights of OtoNexus
OtoNexus has successfully raised a total of $34.79M across 13 strategic funding rounds. The most recent funding activity was a Series C round of $12.9 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Series C — $12.9M
-
First Round
First Round
(01 Jun 2012)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series C - OtoNexus | Valuation |
investors |
|
| Dec, 2021 | Amount | Series C - OtoNexus | Valuation |
investors |
|
| Apr, 2021 | Amount | Series C - OtoNexus | Valuation | Mindshift Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OtoNexus
OtoNexus has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Children's Hospital of Philadelphia, HHS and Mindshift Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Investments are directed by Keiretsu Capital into multiple sectors.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OtoNexus
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OtoNexus
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Otonexus Comparisons
Competitors of OtoNexus
OtoNexus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 3Shape, CellScope, TympaHealth, Lantos and 3NT Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of 3D ear scanning systems
|
|
| domain | founded_year | HQ Location |
In-ear visibility is enabled by smartphone-attached otoscope for at-home diagnosis.
|
|
| domain | founded_year | HQ Location |
Provider of an AI-based hearing health diagnosis device for medical professionals
|
|
| domain | founded_year | HQ Location |
Offers comprehensive solutions for 3D digital ear canal scanning technology.
|
|
| domain | founded_year | HQ Location |
Sinusway device for endoscopy of the nasal cavity & paranasal sinuses
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Otonexus
Frequently Asked Questions about OtoNexus
When was OtoNexus founded?
OtoNexus was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Where is OtoNexus located?
OtoNexus is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Who is the current CEO of OtoNexus?
Caitlin Cameron is the current CEO of OtoNexus. They have also founded this company.
Is OtoNexus a funded company?
OtoNexus is a funded company, having raised a total of $34.79M across 13 funding rounds to date.
What does OtoNexus do?
Developer of an ultrasound device to non-invasively detect middle ear infections or Otitis Media in both children and adults. The doctor points the device at the eardrum, the device then sends an ultrasound signal that detects if fluid is present behind the eardrum, and if so, what type. Currently, doctors often suggest waiting for 24-48 hours to see if the problem resolves before prescribing antibiotics. According to the founder, OtoNexuss handheld doppler ultrasound will eliminate the need to wait.
Who are the top competitors of OtoNexus?
OtoNexus's top competitors include 3Shape, TympaHealth and 3NT Medical.
What products or services does OtoNexus offer?
OtoNexus offers Ultrasound Otoscope.
Who are OtoNexus's investors?
OtoNexus has 6 investors. Key investors include Children's Hospital of Philadelphia, HHS, Mindshift Capital, InnovateHer Seattle, and U.S. Food and Drug Administration.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.